The use of a mixed-treatment comparison to assess the cost-effectiveness of OZURDEX (Dexamethasone 700 ?g intravitreal implant in applicator) compared with bevacizumab intravitreal injections for patients with Macular Oedema following Branch Retinal Vein Occlusion
Authors:
Almond C, Hayward E, Freemantle N and Brereton N.
Publication Type:
Conference Proceedings – Poster
Publication Name:
14th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress
Citation:
Almond C, Hayward E, Freemantle N and Brereton N. The use of a mixed-treatment comparison to assess the cost-effectiveness of OZURDEX®™ (Dexamethasone 700 μg intravitreal implant in applicator) compared with bevacizumab intravitreal injections for patients with Macular Oedema following Branch Retinal Vein Occlusion. 14th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress Madrid, Spain. 5-8 November 2011. Poster PSS26.
